相关实验视频
Updated: Sep 12, 2025

10:29
Generation of Human Chimeric Antigen Receptor Regulatory T Cells
Published on: January 3, 2025
1.6K
与受体结合的正对角IL-2增强了调节性T细胞治疗
bioRxiv : the preprint server for biology
|August 8, 2025
概括
工程调节性T细胞 (Tregs) 现在使用一种新的绑定IL-2系统维持自身,改善了Treg治疗自身免疫性疾病的方法. 这一突破增强了Treg生存和功能,而不需要外部IL-2支持.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 生物技术是生物技术.
背景情况:
- 调节性T细胞 (Treg) 治疗对免疫过度激活有希望,但面临着挑战.
- 输注的Tregs表现出不良的持久性,这是由于其生存和功能至关重要的IL-2 (IL-2) 缺乏.
- 选择性IL-2输送到Tregs很困难,因为IL-2会影响多个免疫细胞.
研究的目的:
- 开发一种增强Treg持久性和治疗疗效的方法.
- 克服工程Tregs对外源IL-2的依赖.
- 创建一个自给自足的Treg系统用于自身免疫性疾病治疗.
主要方法:
- 具有正交IL-2受体 (IL-2R) 的工程Tregs和经过测试的正交IL-2输注.
- 开发了一种与受体结合的直角IL-2系统,用于自身隐性信号传递.
- 在Treg特定表达的Foxp3位点中敲击了绑定的IL-2结构.
主要成果:
- 正交IL-2的输液未能通过工程IL-2R改善Tregs.
- 与受体结合的orthoIL-2在工程Tregs中启用了选择性自克林IL-2信号传递.
- 带有绑定的orthoIL-2的Tregs显示了增强的标记体表达,体内持久性,并有效地预防了自身免疫糖尿病.
结论:
- 一个新的受体绑定的orthoIL-2系统为Treg治疗提供了安全有效的解决方案.
- 这种细胞工程方法克服了Treg对外源IL-2的依赖,增强了治疗潜力.
- 通过Foxp3位点的Treg特异表达增强了IL-2信号和治疗结果.
更多相关视频
07:20Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 14, 2011
14.8K
08:20In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol
Published on: December 30, 2016
20.7K
相关概念视频
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660